Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in South Korea
2 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy
- Where
- Seoul
- Age
- 19 years to 80 years
- People
- 200
- Run by
- Yonsei University
See details and how to joinNCT06580717 - No phaseTaking peopleA Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
- Where
- Seoul
- Age
- 19 years and over
- People
- 600
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06146660